Back

Primary safety results from the LEADLESS observational study

18 June 2017 (15:07 - 15:30)
Organised by:
Congress Presentation Part of: Innovative cardiac devices: do registries help innovation ? Leadless (Pacing) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

3 More presentations in this session

Presentation thumbnail
How does the S-ICD compare with a transvenous ICD? - The EFFORTLESS registry.
Professor P. Lambiase (London, GB)
Slides Video
Presentation thumbnail
The MICRA registry: prime time for the leadless pacemaker?
Doctor N. Clementy (Montpellier, FR)
Slides Video
Presentation thumbnail
Are registries for regulation or for innovation?
Professor J. Camm (London, GB)
Slides Video

Access the full session

Session thumbnail
Innovative cardiac devices: do registries help innovation ?

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June 2017 15:07 CET
You may be interested in
thumbnail
Webinar
Which patients benefit from leadless pacemakers?
25 January 2022
thumbnail
Congress Presentation
Midterm results of the LEADR trial confirm ongoing safety, efficacy, and reliability of the novel, small-diameter OmniaSecure defibrillation lead
31 March 2025
thumbnail
Congress Presentation
Safety profile of a ventricular leadless pacemaker. Data from 1265 patients in the France LEADLESS study.
12 April 2026
thumbnail
Congress Presentation
Leadless pacemaker implantation following transvenous lead extraction: data from i-LEAPER registry
17 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources